NeoGenomics Shares Rise on Executive Succession and Higher Guidance
NeoGenomics (NEO) saw its shares jump 3.6% in pre-market trading following the announcement of an executive succession plan and preliminary updates indicating an increase in full-year guidance.
6% in pre-market trading after it announced an executive succession plan and preliminary updates that point to higher full-year guidance. Under the leadership transition outlined in the update, the company said the changes are part of its succession planning.